￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Duration of venetoclax has no significant effect on OS in AML or MDS

2026-02-01 22:25:32

Check Details
Clinical trial study to determine optimal dosing of aceminib/asinib in children with CML-CP

2026-02-01 22:25:32

Check Details
Narrowband UVB phototherapy increases benefit of ritexitinib in vitiligo

2026-02-01 22:25:32

Check Details
What should I do if I have diarrhea while taking afatinib? Mitigation methods

2026-02-01 22:25:32

Check Details
Global launch time and approved countries of Dali Rayson

2026-02-01 22:25:32

Check Details
Which domestic manufacturers produce Lynparza? How is the quality?

2026-02-01 22:25:32

Check Details
Approximately how long does a box of Veneclax last?

2026-02-01 22:25:32

Check Details
Is Asciminib/Axinib included in Medicare? The latest reimbursement policy in 2025

2026-02-01 22:25:32

Check Details
Can I stop taking ritexitinib? Long-term drug dependence issues

2026-02-01 22:25:32

Check Details
Afatinib maleate is the first generation targeted drug

2026-02-01 22:25:32

Check Details
Clinical efficacy of DaliRasen and real patient feedback

2026-02-01 22:25:32

Check Details
What are the contraindications of Lynparza tablets and what you need to know before using them

2026-02-01 22:25:32

Check Details
Category
相关知识